ORAGENICS, INC. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
ORAGENICS, INC. (OGEN) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $76 as of 2023-12-31, per its 10-K filed 2024-03-29.
Discontinued › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2024-03-29
- 2023-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $76.00.
- 2023-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $381.00.
- 2023-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $10.30K.
- 2023-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $14.49K.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount as first filed |
|---|---|---|
| 2023-12-31 | $76.00 10-K · filed 2024-03-29 | |
| 2023-09-30 | $381.00 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $10.30K 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $14.49K 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $18.81K 10-K · filed 2023-04-17 | |
| 2022-09-30 | $23.55K 10-Q/A · filed 2023-04-14 | |
| 2021-12-31 | $33.16K 10-Q/A · filed 2023-04-14 | $39.96K 10-K · filed 2022-03-24 |
| 2021-09-30 | $47.43K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $55.54K 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $64.27K 10-Q · filed 2021-05-03 | |
| 2020-12-31 | $73.63K 10-K · filed 2021-03-01 | |
| 2020-09-30 | $83.58K 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $94.14K 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $105.28K 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $117.00K 10-K · filed 2020-03-04 | |
| 2019-09-30 | $111.42K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $121.95K 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $2.65K 10-Q · filed 2019-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |